2816 studies found for:    hormone therapy AND (woman OR women OR female)
Hide Display Options

Display Options

Study Details
Participant Details
Rank Status Study
1 Completed The Women's Health Initiative Memory Study (The WHIMS Study)
Condition: Dementia Syndromes
Interventions: Drug: Estrogen hormone therapy;   Drug: Estrogen plus progesterone hormone therapy;   Drug: Placebo
2 Recruiting 1303GCC: Trastuzmab & Pertuzumab With Hormonal Therapy or Chemotherapy in Women Aged 60 and Over.
Condition: Metastatic Breast Cancer
Interventions: Drug: Trastuzumab plus Pertuzumab;   Drug: Hormonal Therapy with Anastrozole and Fulvestrant;   Drug: Chemotherapy with Eribulin
3 Completed Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
Conditions: Hypercholesterolemia;   Postmenopause
Interventions: Drug: L-arginine;   Drug: Estrogen
4 Recruiting Safety Study of Adding Everolimus to Adjuvant Hormone Therapy in Women With High Risk of Relapse, ER+ and HER2- Primary Breast Cancer, Free of Disease After Receiving at Least One Year of Adjuvant Hormone Therapy
Conditions: Primary Non-metastatic Breast Cancer;   Who Remain Disease-free After Receiving at Least 1 Year of Adjuvant Hormone Therapy
Interventions: Drug: Everolimus;   Drug: Placebo
5 Recruiting Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer
Condition: Early Breast Cancer
Intervention: Other: Endocrine therapy interruption
6 Active, not recruiting Prognostic Evaluation of Changing Endocrine Therapy in Women With Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Tamoxifen;   Drug: Toremifene
7 Completed Effect of Surgery, Radiation Therapy, Chemotherapy, and Hormone Therapy on Biomarkers in Women With Stage I, Stage II, Stage III Breast Cancer, or Ductal Carcinoma In Situ That Can Be Removed By Surgery
Condition: Breast Cancer
Interventions: Drug: chemotherapy;   Drug: endocrine therapy;   Genetic: DNA methylation analysis;   Genetic: protein analysis;   Other: laboratory biomarker analysis;   Other: questionnaire administration;   Procedure: adjuvant therapy;   Procedure: conventional surgery;   Radiation: radiation therapy
8 Not yet recruiting Effect of the Pelvic Floor Training in Postmenopausal Women With or Without Hormonal Therapy
Conditions: Weak; Pelvic Floor;   Weak; Muscle;   Urinary Incontinence
Intervention: Behavioral: pelvic floor muscle training
9 Terminated Alopecia Secondary to Endocrine Therapy in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
10 Recruiting Anti-Hormone Therapy (With Anastrazole and Fulvestrant) Before Surgery to Treat Postmenopausal Women With Breast Cancer.
Condition: Invasive Breast Cancer
Interventions: Drug: Fulvestrant;   Drug: Anastrazole
11 Active, not recruiting Expectations and Side Effects of Endocrine Therapy in Women With Breast Cancer
Condition: Female Breast Cancer
Intervention: Behavioral: Enhanced information about endocrine therapy
12 Completed Growth Hormone Treatment of Women With Turner Syndrome
Condition: Turner Syndrome
Interventions: Drug: Growth Hormone;   Drug: Placebo;   Other: Healthy controls
13 Active, not recruiting Compliance to a Hormone Therapy Regimen in Breast Cancer
Condition: Breast Cancer
Interventions: Behavioral: compliance monitoring;   Other: medical chart review;   Other: questionnaire administration
14 Completed Pharmacogenetic Study of Different Hormone Therapies in Recent Menopause Women
Condition: Postmenopause
Interventions: Drug: Estradiol and Progesterone;   Drug: Estradiol and Drospirenone
15 Completed Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer
Condition: Breast Cancer
Intervention: Drug: letrozole
16 Completed Study of Paxil Use in Menopausal Women
Condition: Menopause
Interventions: Drug: Paroxetine;   Drug: placebo
17 Active, not recruiting Tamoxifen Citrate or Letrozole With or Without Bevacizumab in Treating Women With Stage III or Stage IV Breast Cancer
Conditions: Estrogen Receptor Positive;   Progesterone Receptor Positive;   Recurrent Breast Carcinoma;   Stage IIIB Breast Cancer;   Stage IV Breast Cancer
Interventions: Biological: Bevacizumab;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Questionnaire Administration;   Drug: Tamoxifen Citrate
18 Active, not recruiting Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
Condition: Breast Cancer
Interventions: Drug: Letrozole;   Other: Placebo
19 Recruiting MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ
Condition: Ductal Breast Carcinoma In Situ
Interventions: Procedure: Magnetic Resonance Imaging;   Procedure: Therapeutic Conventional Surgery;   Procedure: Therapeutic Surgical Procedure;   Radiation: Radiation Therapy;   Drug: Endocrine Therapy;   Other: Quality-of-Life Assessment;   Other: Laboratory Biomarker Analysis;   Other: Cytology Specimen Collection Procedure
20 Active, not recruiting Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
Conditions: Breast Adenocarcinoma;   Estrogen Receptor and/or Progesterone Receptor Positive;   HER2/Neu Negative;   Stage IA Breast Cancer;   Stage IB Breast Cancer;   Stage IIA Breast Cancer;   Stage IIB Breast Cancer;   Stage IIIB Breast Cancer
Interventions: Drug: Anastrozole;   Drug: Exemestane;   Other: Laboratory Biomarker Analysis;   Drug: Letrozole;   Other: Quality-of-Life Assessment;   Radiation: Radiation Therapy;   Drug: Tamoxifen Citrate

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years